Rapid Micro Biosystems Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance Rapid Micro Biosystems (Nasdaq: RPID) reported record Q4 2025 revenue of $11.3M (+37% YoY) and full year 2025 revenue of $33.6M (+20% YoY). The company placed 28 Growth Direct systems in 2025 and now has 190 cumulative placements with 155 validated.Net loss was $47.1M for 2025 and cash plus short-term investments totaled $39.0M. For 2026 the company forecasts revenue of $37.0M–$41.0M, 30–38 system placements, and gross margins of ~20%.

#RPID Rapid Micro Biosystems Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance

www.stocktitan.net/news/RPID/rapid-micro-bi...

Rapid Micro Biosystems Announces Follow-on Multi-System Order from Samsung Biologics to Expand Deployment of Growth Direct® Platform Rapid Micro Biosystems (Nasdaq: RPID) announced a follow-on multi-system order from Samsung Biologics on March 12, 2026 to expand deployment of the Growth Direct platform.The order strengthens the companies' partnership and supports Samsung's expansion of automated microbial quality control across its manufacturing network, aiming for faster results, greater accuracy, and improved data integrity.

#RPID Rapid Micro Biosystems Announces Follow-on Multi-System Order from Samsung Biologics to Expand Deployment of Growth Direct® Platform

www.stocktitan.net/news/RPID/rapid-micro-bi...

Rapid Micro Biosystems Announces Record Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue Fourth quarter 2025 total revenue expected to be approximately $11.3 million, representing growth of approximately 37% compared to the prior-year period. Received record multi-system order in the fourth quarter from an existing Top 20 global biopharma customer to automate global manufacturing

#RPID Rapid Micro Biosystems Announces Record Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue

www.stocktitan.net/news/RPID/rapid-micro-bi...

Rapid Micro Biosystems to Announce Third Quarter 2025 Financial Results on November 7, 2025 Rapid Micro Biosystems (Nasdaq: RPID) will release third quarter 2025 financial results before market open on Friday, November 7, 2025.The company's management will host a webcast conference call at 8:30 a.m. ET on November 7, 2025 to discuss results; the live audio webcast is accessible on the company website and will be archived for replay.

#RPID Rapid Micro Biosystems to Announce Third Quarter 2025 Financial Results on November 7, 2025

www.stocktitan.net/news/RPID/rapid-micro-bi...

Trinity Capital Inc. Provides $45 Million in Growth Capital to Rapid Micro Biosystems, Modernizing Healthcare Industry Practices PHOENIX, Sept. 22, 2025/ PRNewswire/-- Trinity Capital Inc., a leading alternative asset manager, today announced the commitment of $45 million in growth capital to Rapid Micro Biosystems, an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of...

#TRIN #RPID Trinity Capital Inc. Provides $45 Million in Growth Capital to Rapid Micro Biosystems, Modernizing Healthcare Industry Practices

www.stocktitan.net/news/TRIN/trinity-capita...

Rapid Micro Biosystems Reports Second Quarter 2025 Financial Results Rapid Micro Biosystems (NASDAQ:RPID) reported Q2 2025 financial results, with total revenue reaching $7.3 million, up 10% year-over-year. The company demonstrated strong performance with recurring revenue growing 15% to $4.4 million and service revenue increasing 18% to $2.5 million.The company secured a significant $45 million term loan facility with Trinity Capital, with $20 million funded at closing. Despite a net loss of $11.9 million, RPID showed improvement in gross margin, reaching positive 4% compared to negative 3% in Q2 2024. The company placed four new Growth Direct systems and completed two system validations during the quarter.RPID reaffirmed its full-year 2025 revenue guidance of at least $32.0 million. The company ended Q2 with approximately $32 million in cash, cash equivalents, short-term investments, and restricted cash.

#RPID Rapid Micro Biosystems Reports Second Quarter 2025 Financial Results

www.stocktitan.net/news/RPID/rapid-micro-bi...

Rapid Micro Biosystems Lands $45M Term Loan to Accelerate Global Growth Direct System Expansion $20M immediately available with $25M in milestone-linked tranches. Strategic funding backs commercial expansion and operational improvements. See growth plans.

#RPID Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc.

www.stocktitan.net/news/RPID/rapid-micro-bi...

Life Sciences Tech Leader Rapid Micro Biosystems Sets Q2 2025 Earnings Date - Key Details for Investors Mark your calendar: Q2 2025 results and live webcast scheduled for August 12 at 8:30 AM ET. Access earnings call details and replay options here. Get insights.

#RPID Rapid Micro Biosystems to Announce Second Quarter 2025 Financial Results on August 12, 2025

www.stocktitan.net/news/RPID/rapid-micro-bi...

Rapid Micro Biosystems Reports First Quarter 2025 Financial Results Rapid Micro Biosystems (NASDAQ: RPID) reported strong Q1 2025 financial results with total revenue of $7.2 million, representing a 28% growth year-over-year. The company achieved record quarterly service revenue of $3.1 million, up 64% from Q1 2024. Product revenue increased 10% to $4.1 million, while recurring revenue grew 6% to $4.0 million.Notable achievements include placing three new Growth Direct® systems and completing nine customer system validations. Gross margin improved significantly to positive 6% from negative 27% in Q1 2024. Operating expenses decreased 5% to $12.1 million, and net loss improved to $11.3 million ($0.26 per share) from $13.3 million ($0.31 per share) year-over-year.The company announced a global Distribution and Collaboration Agreement with MilliporeSigma and reaffirmed its 2025 revenue guidance of at least $32.0 million, targeting 21-25 system placements.

#RPID Rapid Micro Biosystems Reports First Quarter 2025 Financial Results

www.stocktitan.net/news/RPID/rapid-micro-bi...

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Small-cap stocks with improving money flow, Tue Apr 15th - #RPID #TRVI #NG #MSGM #LEDS #INVA #HITI #GNPX #ENSC #VINC #RBBN #CSLR #ADAG #ZVIA #UTZ #PRG #FUBO #FBMS - More: crystalequityresearch.com/SmCpStr/ - #smallcap

What’s Changing for Refugee Claimants in Canada? The New RPID Explained | Bellissimo Law Group

"The Refugee Protection Identity Document (RPID) will soon replace the RPCD for refugee claimants in Canada. Find out how this new ID will affect access to health services and more: www.bellissimolawgroup.com/whats-changi...
#Refugees #Refugee #Canada #Immigration #RPID #cdnimm

Can Rapid Micro's 30% Revenue Growth and MilliporeSigma Deal Transform Its Path to Profitability? RPID achieves record $8.2M quarterly revenue with 12% gross margin, announces strategic MilliporeSigma partnership, and projects minimum $32M revenue for 2025.

#RPID Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Guidance

www.stocktitan.net/news/RPID/rapid-micro-bi...

Can This New MilliporeSigma Partnership Transform Rapid Micro Biosystems' Market Reach? Partnership includes minimum purchase commitments for Growth Direct systems and explores manufacturing cost savings while expanding global market access.

#RPID Rapid Micro Biosystems Announces Global Distribution and Collaboration Agreement with the Life Science business of Merck KGaA, Darmstadt, Germany

www.stocktitan.net/news/RPID/rapid-micro-bi...

Q4 Earnings Preview: Will Rapid Micro's Automation Solutions Drive Growth in 2025? Join management for a comprehensive review of Q4 and full-year performance in healthcare automation solutions, with forward-looking insights for 2025

#RPID Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025

www.stocktitan.net/news/RPID/rapid-micro-bi...

Rapid Micro Biosystems Achieves Record Q4 Revenue, Partners with Lonza for Automated QC Solution Q4 revenue surged 30% to $8.2M with strong system placements. Strategic Lonza partnership creates first automated end-to-end environmental monitoring solution for cell therapy.

#RPID Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenue

www.stocktitan.net/news/RPID/rapid-micro-bi...

News; ( NASDAQ: #RPID ) Rapid Micro Biosystems Reports Third Quarter 2024 Financial Results

#StockMarket #News

Just In: ( NASDAQ: #RPID ) Rapid Micro Biosystems Reports Second Quarter 2024 Financial Results

#StockMarket #News